Dr. Garret Choby

Garret W. Choby, MD, is an Associate Professor of Otolaryngology – Head and Neck Surgery, as well as Neurological Surgery at the University of Pittsburgh School of Medicine. He specializes in sinus and skull base surgery.

Dr. Choby completed his otolaryngology residency at the University of Pittsburgh followed by fellowship training in rhinology and skull base surgery at Stanford University. Following training, he joined the faculty at the Mayo Clinic in Rochester, MN, with joint appointments in the Departments of Otolaryngology and Neurosurgery, where he served as the Chair of Quality and had a domestic and international referral practice for sinonasal cancers, skull base tumors and refractory sinus disease. He was subsequently recruited back to UPMC where he serves in his current role.

Dr. Choby is a diplomate of the American Board of Otolaryngology and a member of the American Academy of Otolaryngology – Head & Neck Surgery, the American Rhinologic Society (ARS), and the North American Skull Base Society. He is a nationally recognized leader in sinus and skull base disorders, as well as surgical quality. He is a regular invited lecturer nationally and internationally. He has previously been named departmental Teacher of the Year and is a 3x recipient of the Press-Ganey patient experience award. Dr. Choby has held several national leadership positions including the Chair of the Skull Base and Orbital Surgery section of the ARS.

Dr. Choby’s clinical focus includes sinonasal cancers, skull base tumors and inflammatory sinus disease. He enjoys a collaborative practice with his neurosurgical colleagues, offering comprehensive care for patients with complex skull base tumors. Active research areas include improving quality of life following endoscopic skull base surgery and improving survival in patients with sinonasal malignancies. Highlights of ongoing studies include proliferative and transcriptomic profiling of sinonasal mucosal melanoma, understanding outcomes of olfactory neuroblastoma and a multi-site consortium prospectively evaluating survival outcomes and tumor biology of sinonasal malignancies. He has published over 150 peer-reviewed manuscripts.